Stryker fundamentals

Use Stryker Corporation fundamentals together with your other stock asset holdings to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.  Optimize Portfolio

Stryker Corporation is rated fifth in shares outstanding category among related companies. It is rated below average in one year high category among related companies . The ratio of Shares Outstanding to One Year High for Stryker Corporation is about  5,666,567 

Shares Outstanding

Return On Equity Return On Asset Profit Margin Operating Margin Current Valuation Shares Outstanding Shares Owned by Insiders Shares Owned by Institutions Number of Shares Shorted Price to Earning Price to Book Price to Sales Revenue Gross Profit EBITDA Net Income Cash and Equivalents Cash per Share Total Debt Debt to Equity Current Ratio Book Value Per Share Cash Flow from Operations Short Ratio One Year High One Year Low Earnings Per Share Price to Earnings To Growth Number of Employees Beta Market Capitalization Total Asset Retained Earnings Working Capital Current Asset Current Liabilities Z Score Probability Of Bankruptcy

Stryker competes with ABBOTT, MEDTRONIC, INTUITIVE, BOSTON, and ST JUDE. Its Reconstructive segment offers orthopaedic reconstructive implants used in hip and knee joint replacements; and trauma implant systems, as well as other related products. Stryker Corporation?s MedSurg segment offer surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment, and reprocessed and remanufactured medical devices, as well as other medical device solutions for use in various medical specialties. Stryker Corporationration?s Neurotechnology and Spine segment offers neurosurgical and neurovascular devices, which include solutions for use in endovascular techniques, solutions for use in traditional brain and open skull base surgical procedures, and orthobiologic and biosurgery products, as well as solutions for the treatment of acute ischemic and hemorrhagic stroke. This segment also develops, manufactures, and markets spinal implant products, such as cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. Stryker Corporation sells its solutions through direct sales, and thirdparty dealers and distributors in the United States and approximately 100 countries worldwide. Stryker Corporationration was founded in 1941 and is headquartered in Kalamazoo, Michigan.